Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery

Table 3 Baseline characteristics of patients with progression of native coronary artery at 5-year follow-up

Characteristics	Progression (n= 286)	Nonprogression (109)	p
Demographic profile
Age, y	60 ± 9	60 ± 10	0.147
Female (%)	28	35	0.191
Medical history (%)
Current Smoker	28	32	0.268
Hypertension	59	56	0.635
Myocardial infarction(yes/no)	68/77	32/23	0.052
Diabetes	34	37	0.615
CCS class I or III angina	86	90	0.297
Laboratory values, mmol/L
Total cholesterol	222 ± 46	221 ± 46	0.964
LDL cholesterol	149 ± 39	147 ± 39	0.658
HDL cholesterol	37 ±10	38 ±10	0.078
Triglycerides	188 ± 115	190 ± 114	0.395
Medications
Beta-blockers	74	78	0.247
Calcium channel antagonists	62	42	0.020
Long-acting nitrates	86	83	0.414
ACE inhibitors	31	34	0.564
HMG-CoA reductase inhibitors	20	15	0.335
Aspirin	94	96	0.331
Entry angiographic features
Double-vessel disease, %	49	39	0.072
Triple-vessel disease, %	51	61
Collateral circulation	38	53	0.011
Treatment Received, %
PCI	45	23
CABG	23	47	< 0.001
MT	32	30
Total Events (yes, no)	76/71	24/29	0.397
New CABG, %	7	11	0.168
New PCI, %	13	9	0.252
AMI	8	5	0.252
Angina 5 years, (yes, no)	42	30	0.024

ISSN: 1749-8090